Who has invested in Pear Therapeutics?

SoftBank are named among the investors backing Pear Therapeutics.

Pear Therapeutics Funding: $250M Raised, Series D

Pear Therapeutics funding overview

Pear Therapeutics is based in Boston, MA. Pear Therapeutics has raised $250M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D. Investors on record include SoftBank.

Pear Therapeutics at a glance

Total raised: $250M
Latest round: Series D
Headquarters: Boston, MA
Notable investors: SoftBank

Frequently asked about Pear Therapeutics funding

How much has Pear Therapeutics raised?: Pear Therapeutics has raised $250M in total disclosed funding across the rounds on record.
Who has invested in Pear Therapeutics?: SoftBank are named among the investors backing Pear Therapeutics.
What was the latest Pear Therapeutics funding round?: The most recent disclosed round is a Series D.
Where is Pear Therapeutics based?: Pear Therapeutics is based in Boston, MA.

Round data for Pear Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Boston and backer lists below.

Pear Therapeutics Funding: $250M Raised, Series D

Pear Therapeutics funding overview

Pear Therapeutics at a glance

Frequently asked about Pear Therapeutics funding

Companies related to Pear Therapeutics (36)

Browse related funding lists (4)